Dose distribution along the transverse axis of a new 125I source for interstitial brachytherapy
- 9 November 2000
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 27 (11) , 2536-2540
- https://doi.org/10.1118/1.1319520
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Long-term complications with prostate implants: Iodine-125 vs. palladium-103Radiation Oncology Investigations, 1999
- Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sourcesMedical Physics, 1998
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43Medical Physics, 1995
- Short-term freedom from disease progression after I-125 prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Comparison of radiation dosimetry in water and in solid phantom materials for I‐125 and Pd‐103 brachytherapy sources: EGS4 Monte Carlo studyMedical Physics, 1994
- Brachytherapy and organ preservation in the management of carcinoma of the prostateSeminars in Radiation Oncology, 1993
- Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sourcesMedical Physics, 1990
- A protocol for the determination of absorbed dose from high‐energy photon and electron beamsMedical Physics, 1983